drugset / Trial / NCT01818414

Same-day Dilapan-S With Adjunctive Misoprostol

NCT01818414

Terminated 29 enrolled University of Pittsburgh
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cervical preparation before second trimester dilation and evacuation (D\&E) reduces risks and complications. Osmotic cervical dilators as well as prostaglandin analogues have been studied for cervical preparation. However, the optimal method for cervical preparation, especially for D\&E procedures that occur on the same day as cervical preparation, is not known. This study will investigate misoprostol versus placebo as an adjunct to Dilapan-S for cervical preparation for same-day D\&E between 16+0 and 20+6 weeks gestation. HYPOTHESIS: Administration of 400 µg buccal misoprostol compared to placebo at least 3 hours prior to D\&E as an adjunct to cervical preparation with Dilapan-S will decrease operative time for same-day D\&E performed between 16+0 and 20+6 weeks.

Timeline

Start
2013-10
Primary completion
2014-03
Completion
2014-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.